Juniper Pharmaceuticals Inc (NASDAQ:JNP)

9.10
Delayed Data
As of Jun 22
 +0.20 / +2.25%
Today’s Change
4.30
Today|||52-Week Range
13.25
+87.63%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$96.6M

Company Description

Juniper Pharmaceuticals, Inc., is a pharmaceutical company. It is engaged in the development of therapeutics that addresses unmet medical needs in women's health. The company operates through product, and service segments. The product segment oversees the supply chain and manufacturing of crinone. The service segment includes product development, clinical trial manufacturing, and advanced analytical & consulting services. Juniper Pharmaceuticals was founded in December 1986 and is headquartered in Boston, MA.

Contact Information

Juniper Pharmaceuticals, Inc.
33Arch Street
Boston Massachusetts 02110
P:(617) 639-1500
Investor Relations:

Employees

Shareholders

Individual stakeholders7.78%
Other institutional33.33%
Mutual fund holders12.21%

Top Executives

Alicia SecorPresident, Chief Executive Officer & Director
Nikin PatelChief Operating Officer & Director
Jeffrey E. YoungChief Financial Officer, Secretary & Treasurer
Shen LukChief Scientific Officer